Press Room

News / Dec 05, 2021

Hovione Cork renews its certification of The Business Working Responsibly Mark

A recognition for CSR practices at the site and its positive impact on both the workplace and the wider community

Hovione wins business working responsibility mark

Recently the Hovione Cork site achieved certification of The Business Working Responsibly Mark for the second time, having first achieved the Mark in 2018. The Mark is the leading independently audited standard for Corporate Social Responsibility (CSR) and Sustainability certification in Ireland and is based on ISO26000. The Mark assessment process involved a root to branch review of Hovione's corporate social responsibility and sustainability management systems across five pillars - Governance, Workplace, Marketplace, Environment and Community.

 

“The awarding of the certification for another 3 years is great recognition of the work and dedication that the team in Cork have to continuously improving and developing the CSR standards and practices at the site and its positive impact on both the workplace and the wider community”, said Louise Dennehy.

Business Working Responsibility Mark logo | Hovione

 

The process for recertification began in April this year lead by Louise Dennehy, HR Business Partner, Marguerite Lynch, HSE Manager - Environment, Bruno Dias, OpEx Specialist and Maureen O'Leary, Procurement Manager with the audit taking place virtually at the end of October. Along with a full process and documentation review, 4 team members were interviewed by the assessor on their knowledge, awareness and understanding of the company’s CSR activities.

 

You might be also interested in:

 

Also in the Press Room

See All

Continuous Tableting (CT) is defined as continuous manufacturing of oral dose drugs, specifically tablets. As per ICH's Q13 definition1, a continuous manufacturing process in the pharmaceutical industry comprises at least two unit operations integrated from a mechanical and software perspective. There is a wide combination of possible CT process configurations that are dependent on the needs of the intended product formulation and each of the individual unit operations that constitute the process train can be continuous, semi-continuous, or batch processes. The typical manufacturing processes for tablet formulation are direct compression (DC), dry granulation (DG) and wet granulation (WG)2 - details on these manufacturing processes are beyond the scope of this article, so the interested reader is directed to relevant literature. The actual implementation of CT technology in a facility can broadly vary depending on the level of desired integration and automation. Process trains can be designed to be flexible and converted between multiple configurations (e.g. continuous DC, DG and WG), controlled by the end user from one single software and within a single clean room. The other possibility would be for subsections of the CT process to be divided into multiple clean rooms where inprocess materials are transferred between suites via a bin-to-bin approach (e.g. a granulation suite to prepare granules from raw materials followed by continuous DC (CDC) to blend the granules and produce tablets). The level of automation and instrumentation designed into the CT process (typically involving Process Analytical Technologies, PAT) can open the possibility to implement sophisticated control strategies. Key components of a control strategy that need to be considered for CT are material tracking and genealogy, knowledge of the residence time distribution (RTD), and in-process controls (spectroscopic and/or soft sensors based on process parameters). Holistically, these control strategy elements enable the implementation of a material diversion strategy to automatically divert out of specification material from the process. In their most advanced form, control strategies may also enable real time release testing (RTRt) of the final tablet drug product and reduce the off-line analytical burden and the number of operators needed to manage the process.   Read the full article at gmp-journal.com  

Article

Continuous Tableting and the Road to Global Adoption

Mar 04, 2024